Last reviewed · How we verify
NCT07229963
Exercise Intensity and Postprandial Effects of Breaking Sedentary Behavior in Overweight Adults
NA trial testing Aerobic Exercise Intervention in Cardiovascular Risk Markers in 16 participants. Not yet recruiting.
25 April 2026
Quick facts
| Lead sponsor | Hacettepe University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 16 |
| Start date | 25 November 2025 |
| Primary completion | 25 April 2026 |
| Estimated completion | 15 June 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Aerobic Exercise Intervention
- Sprint Exercise Intervention
- Sedentary Behaviour Intervention
Conditions studied
- Cardiovascular Risk Markers — all drugs for Cardiovascular Risk Markers →
- Substrate Oxidation — all drugs for Substrate Oxidation →
- Postprandial Metabolism — all drugs for Postprandial Metabolism →
- Exercise Physiology — all drugs for Exercise Physiology →
Sponsor
Hacettepe University
Who can join
Adults 35 to 45, any sex, with Cardiovascular Risk Markers or Substrate Oxidation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is twofold: (1) to determine whether breaking up prolonged sitting with aerobic or sprint cycling breaks reduces postprandial blood glucose, insulin, CRP, and blood pressure, which are established risk markers for cardiometabolic diseases; and (2) to assess substrate oxidation during this period in order to identify which exercise condition promotes the greatest increase in fat oxidation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07229963
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aerobic Exercise Intervention
Trials testing the same drug.
- NCT07059884 — Distance-Based Exercise to Preserve Function and Prevent Disability · NA · recruiting
- NCT04667481 — Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE · NA · completed
- NCT03592238 — Sympathetic Nervous System Mediation of Acute Exercise Effects on Childhood Brain and Cognition · NA · completed
- NCT03162991 — Aerobic Treadmill Exercise And Metabolism · NA · completed
- NCT03648762 — Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit · NA · completed
Other Hacettepe University trials
Trials by the same sponsor.
- NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
- NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
- NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
- NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
- NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07229963 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
- Last refreshed: 17 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07229963.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing